Inhibitors of nf-kb

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 303/36 (2006.01) A61K 31/336 (2006.01) A61K 31/409 (2006.01) A61K 31/428 (2006.01) A61K 31/4375 (2006.01) A61K 31/4427 (2006.01) A61K 31/4725 (2006.01) A61K 31/497 (2006.01) A61K 31/501 (2006.01) A61K 31/506 (2006.01) C07D 405/12 (2006.01) C07D 407/12 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01) C07D 471/04 (2006.01)

Patent

CA 2755910

The invention relates to compounds of formulae (1) and (2), and pharmaceutically acceptable salts thereof for the treatment of cancer, inflammation, auto-immune diseases, diabetes and diabetic complications, infection, cardiovascular disease and ischemia-reperfusion injuries.

La présente invention concerne des composés de formule (1) et (2), ainsi que leurs sels pharmaceutiquement acceptables, utilisables dans le cadre du traitement du cancer, de l'inflammation, des maladies auto-immunes, du diabète et de ses complications, de l'infection, des maladies cardiovasculaires et des lésions d'ischémie-reperfusion.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inhibitors of nf-kb does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of nf-kb, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of nf-kb will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1528715

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.